Europe's new heart plan rests on data showing a twofold mortality gap inside the continent

The European Union adopted a cardiovascular health plan — the Safe Hearts Plan — in December 2025 [s1]. The statistical report that fed its evidence base has now been published, and it makes clear that the plan's hardest problem is not Europe's cardiovascular burden in aggregate. It is how unevenly that burden is distributed between European countries.

The ESC Atlas project's 2025 report, published in the European Heart Journal this month, is the fifth in a biennial series [s1]. It presents and compares cardiovascular disease statistics for more than 50 European Society of Cardiology member countries, using data for 2024 or the latest available year, and stratifies them by sex and by World Bank national income status [s1]. That second stratification is what turns a statistics compendium into a policy document.

The headline burden

Across ESC member countries, the Atlas reports 68 million disability-adjusted life years attributable to cardiovascular disease, in association with more than three million deaths per year [s1]. Cardiovascular disease remains the leading cause of death across those countries [s1].

Population ageing is identified as a major contributor to the continuing high prevalence [s1]. That is worth holding onto, because it means falling age-standardised rates and a rising absolute burden can happen simultaneously — a pattern that regularly produces contradictory headlines about whether heart disease is getting better or worse.

The gap the plan has to close

The inequality finding is the report's recurring theme. Middle-income ESC member countries show age-standardised cardiovascular mortality rates roughly twice those observed in high-income countries [s1].

That is not a marginal difference. It is a doubling, inside a continent that shares a regulatory framework for medicines and devices and a substantial body of common clinical guidance.

The Atlas attributes part of it to differences in healthcare delivery rather than to risk factors alone, identifying marked disparities in workforce capacity and in access to advanced interventions [s1]. Those disparities recur throughout the report and are flagged as clear priorities for policymakers developing strategies where the need is greatest [s1].

The distinction matters for what a European plan can realistically do. Risk-factor gaps — smoking, blood pressure, obesity — respond to population-level policy over decades. Workforce and access gaps are questions of capital, training pipelines and reimbursement, and they sit almost entirely with national governments rather than with Brussels. A continental plan can set targets and move some money; it cannot staff a catheterisation laboratory.

That tension was already being examined in the literature before this report appeared: a comment in The Lancet Diabetes & Endocrinology in January took up the question of country-level implementation of the Safe Hearts Plan [s2].

The headwind

The Atlas is not a report about steady progress. Its framing is that gains made in reducing cardiovascular burden across ESC member countries are at risk of being offset by new challenges — particularly the epidemic of obesity and diabetes, which the authors describe as continuing to undermine cardiovascular health [s1].

This is the structural problem behind most European cardiovascular policy at the moment. The clinical toolkit for treating established cardiovascular disease has improved substantially. The upstream metabolic risk driving new disease has moved in the other direction. Whether the first outruns the second is an open empirical question, and the Atlas does not claim to answer it.

The report also emphasises the interplay between demography, environment, socio-economic status and clinical factors in shaping cardiovascular risk [s1] — which is another way of saying that no single lever in the plan is likely to be decisive on its own.

What this is, and is not

The ESC Atlas is a compilation, not a study. It aggregates national and international data sources of varying completeness across more than 50 countries, and the quality of any cross-national comparison is bounded by the weakest reporting system in it. Countries with less developed registries tend to be exactly the countries where burden is highest, which can bias comparisons in either direction depending on whether under-ascertainment or misclassification dominates.

It also reports association, not attribution. Saying that 68 million disability-adjusted life years are attributable to cardiovascular disease is a burden-of-disease calculation resting on modelled assumptions, not a count of records.

What it does provide is a consistent, repeated instrument. Because this is the fifth report in a biennial series using a common method, the trends inside it are more informative than any single year's numbers [s1].

What to watch

The near-term test of the Safe Hearts Plan is whether it moves resources toward the middle-income member countries where the twofold mortality gap sits, or whether it functions mainly as a coordinating framework for countries already doing well. The next Atlas edition, two years out, is the instrument that will show which happened.

Sources

• [s1] European Society of Cardiology: cardiovascular disease statistics 2025 — European Heart Journal, published online 19 May 2026. https://doi.org/10.1093/eurheartj/ehag345
• [s2] Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health — The Lancet Diabetes & Endocrinology, published online 29 January 2026. https://doi.org/10.1016/S2213-8587(26)00004-5